CN114432235B - Preparation method of difunctional slow-release supermolecule hydrogel for injection - Google Patents

Preparation method of difunctional slow-release supermolecule hydrogel for injection Download PDF

Info

Publication number
CN114432235B
CN114432235B CN202210181285.8A CN202210181285A CN114432235B CN 114432235 B CN114432235 B CN 114432235B CN 202210181285 A CN202210181285 A CN 202210181285A CN 114432235 B CN114432235 B CN 114432235B
Authority
CN
China
Prior art keywords
preparation
radix scutellariae
solution
stock solution
hydrogel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210181285.8A
Other languages
Chinese (zh)
Other versions
CN114432235A (en
Inventor
冯传良
孙萌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Jiaotong University
Original Assignee
Shanghai Jiaotong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Jiaotong University filed Critical Shanghai Jiaotong University
Priority to CN202210181285.8A priority Critical patent/CN114432235B/en
Publication of CN114432235A publication Critical patent/CN114432235A/en
Application granted granted Critical
Publication of CN114432235B publication Critical patent/CN114432235B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a preparation method of a difunctional slow-release type supermolecule hydrogel for injection, which comprises the following steps: step 1: extracting radix Scutellariae with ethanol under ultrasonic condition to obtain radix Scutellariae extract; step 2: dissolving chiral gel factor LBA with ethanol to prepare high-concentration stock solution; step 3: mixing Scutellariae radix extract with chiral gel factors of different concentrations; step 3: adding deionized water into the mixed solution, and standing to form the gel. The chiral supramolecular hydrogel is used as a gelling agent, the baical skullcap root extract is used as a functional substance, the former is generated through non-covalent bond interaction with small molecules in the baical skullcap root extract, other organic solvents, stabilizers and other substances are not needed to be added in the preparation process, and the preparation process is simple, mild, green, safe and nontoxic, and ensures the safety of operators.

Description

Preparation method of difunctional slow-release supermolecule hydrogel for injection
Technical Field
The invention relates to the technical field of material preparation, in particular to a preparation method of a difunctional slow-release type supermolecule hydrogel for injection.
Background
Inflammatory bowel disease (inflammatory bowel disease, IBD) is a chronic non-specific disease with an undefined pathogenesis and mainly involves the intestinal tract, and in recent years, the number of people suffering from IBD in China is on an increasing trend, and the demand for therapeutic drugs is also increasing. Although a great deal of research results have been applied to the treatment of IBD, to some extent, the effects of long-term maintenance and alleviation, promotion of tissue healing, reduction of hospitalization rate and operation rate are achieved, there are many adverse reactions and potential safety hazards, such as inhibition of human immune function, bacterial resistance, etc. The Chinese medicine has the functions of regulating intestinal flora disorder, maintaining intestinal flora steady state and diversity, and has positive effects on IBD treatment, such as spleen invigorating and intestine benefiting pill, red intestine relieving and exogenously clearing pill, compound kuh-seng enteritis rehabilitation tablet, etc. However, the material basis of the action of traditional Chinese medicine is not clear, which hinders the further development of traditional Chinese medicine treatment. Systematic research on single traditional Chinese medicines becomes a trend of disease treatment, and the common property of the three traditional Chinese medicine compounds is inspired, and the discovery that the traditional Chinese medicine compounds all contain the baikal skullcap root indicates that the baikal skullcap root has a certain potential application value for treating enteritis. In fact, the radix Scutellariae slice is currently applied to the treatment of related diseases such as inflammation diminishing and detoxification, however, the absorption performance of the radix Scutellariae slice is poor, which affects the use of the radix Scutellariae slice as a medicament for treating IBD.
The baical skullcap root contains a plurality of molecules with potential therapeutic effects, such as baicalein, wogonin, baicalin, oroxylin and the like, and has been reported to be applied to the fields of antibiosis and anti-inflammatory. The traditional Chinese medicine has multi-target effect, and the molecules can act synergistically. The use of a single molecule for disease treatment is difficult to address interactions between multiple targets, and thus co-delivery of multiple small active molecules is an attractive area of research for the treatment of IBD. The supermolecular hydrogel has wide medical application prospect, the supermolecular hydrogel system has a plurality of binding sites, can be combined with guest molecules through non-covalent bond interaction, and can generate reversible responsiveness to external environment due to weaker combining capability. Unfortunately, there is no current research on the multicomponent co-delivery of drugs by supramolecular hydrogels.
Disclosure of Invention
The invention aims at solving the problems existing in the prior art, provides a preparation method of a difunctional slow-release type supermolecule hydrogel for injection, and particularly relates to a preparation method of a supermolecule hydrogel co-delivery system based on chiral characteristics. The method has simple preparation process, safety, environmental protection, and antibacterial, antioxidant and long-acting release functions.
In order to achieve the above purpose, the invention adopts the following technical scheme:
the invention provides a preparation method of a difunctional slow-release type supermolecule hydrogel for injection, which comprises the following steps:
s1, weighing radix scutellariae, grinding and extracting to obtain radix scutellariae extract;
s2, weighing supermolecule chiral gel factors, and adding ethanol to prepare high-concentration stock solution;
s3, uniformly mixing the high-concentration stock solution with the scutellaria baicalensis extracting solution, and then adding deionized water;
s4, standing to obtain the supermolecule hydrogel.
As an embodiment of the present invention, the method of extraction in step S1 specifically includes: adding ethanol into crushed radix Scutellariae, ultrasonic extracting at 40-70deg.C for 40-60 min at a ratio of 10:40-50, repeating the extraction for 4-5 times, mixing the extractive solutions, and concentrating to obtain radix Scutellariae extractive solution.
As an embodiment of the present invention, the root of scutellaria baicalensis in step S1 is a dried, processed root of scutellaria baicalensis.
As an embodiment of the present invention, the supramolecular chiral gelator in step S2 is LBA, and the structure is as follows:
Figure BDA0003521093830000021
as one embodiment of the present invention, the concentration of chiral gelator LBA in the high concentration stock solution in step S2 is 25-35mg/ml. The concentration is preferably 30mg/ml.
As one embodiment of the present invention, the volume ratio of the high concentration stock solution to the scutellaria baicalensis extract in the step S3 is 1:1.5-1:3.5. The volume ratio of the high concentration stock solution to the scutellaria baicalensis extract is preferably 1:2.8. When the volume ratio is too large, the mechanical strength of the gel is lowered, possibly resulting in burst release of the supported substance.
As one embodiment of the invention, the volume of deionized water in the step S3 is 5-10 times of the volume of the mixed high-concentration stock solution and the scutellaria baicalensis extracting solution. The volume ratio is preferably 7 times.
As an embodiment of the present invention, the supramolecular hydrogel in step S4 is a pale yellow gel.
The invention also provides a preparation method of the difunctional slow-release type supermolecule solution for injection, which comprises the following steps:
a1, weighing radix scutellariae, grinding and extracting to obtain radix scutellariae extract;
a2, weighing chiral gel factor LBA, and adding ethanol to prepare high-concentration stock solution;
a3, uniformly mixing the high-concentration stock solution with the scutellaria baicalensis extracting solution to obtain the solution.
The hydrogel injected by the solution can be gelled instantaneously, and is convenient for slow administration.
The invention provides a difunctional slow-release type supermolecule hydrogel which is prepared by the preparation method and can be used for injection.
The invention provides a difunctional slow-release type supermolecule solution which is prepared by the preparation method and can be used for injection.
Compared with the prior art, the invention has the following beneficial effects:
1. according to the preparation method of the supramolecular hydrogel based on chiral characteristics, provided by the invention, the dressing is endowed with the antioxidant, anti-inflammatory and antibacterial properties by adopting the baical skullcap root extract, and the chiral gel factor LBA is taken as a gelling agent, so that a plurality of active molecules can be loaded simultaneously to exert the treatment effect, other reactions are not required to be introduced in the preparation process, and the preparation process is simple and mild, green, safe and nontoxic, and ensures the safety of operators; the hydrogel prepared by the invention has good antioxidation and antibacterial properties and long-acting slow release performance;
2. the hydrogel prepared by the invention has simple components and easy preparation;
3. although the prior patent (CN 112641995B) also uses the supermolecular gel and the traditional Chinese medicine components of the patent, the obtained hydrogel is a gel block with high strength, is suitable for wound repair and is not suitable for enteritis treatment. The supermolecular gel system prepared by the invention has the characteristic of rapid gelation, and can be applied to enteritis.
Drawings
Other features, objects and advantages of the present invention will become more apparent upon reading of the detailed description of non-limiting embodiments, given with reference to the accompanying drawings in which:
FIG. 1 is a schematic diagram of an example preparation gel and an antibacterial test thereof, wherein A is a preparation appearance diagram of a bifunctional supramolecular hydrogel; b is a preparation appearance diagram of the difunctional supermolecule hydrogel; c is an antibacterial diagram test schematic diagram of the supramolecular hydrogel;
FIG. 2 is a graph of radical scavenging for supramolecular hydrogels prepared at different volume ratios;
figure 3 is a graph showing the effect of different volume ratios of hydrogels on slow release of active molecules.
Detailed Description
The invention will now be described in detail with reference to the drawings and specific examples. The following examples, which are presented to provide those of ordinary skill in the art with a detailed description of the invention and to provide a further understanding of the invention, are presented in terms of implementation and operation. It should be noted that the protection scope of the present invention is not limited to the following embodiments, and several adjustments and improvements made on the premise of the inventive concept are all within the protection scope of the present invention.
Example 1
The embodiment provides a preparation method of a bifunctional supermolecule hydrogel, which comprises the following steps:
step 1: weighing 10g of radix scutellariae, grinding, adding 40mL of ethanol, carrying out ultrasonic treatment, filtering, collecting filtrate, repeatedly extracting for 4 times, and concentrating under reduced pressure to 50mL to obtain radix scutellariae extract;
step 2: weighing LBA, adding ethanol, and preparing 30mg/ml stock solution;
step 3: uniformly mixing 100 mu L of LBA high-concentration stock solution and baical skullcap root extract (200 mu L), and then adding deionized water with the volume of 7 times;
step 4: after standing, a supramolecular hydrogel can be obtained, as shown in FIG. 1A. The obtained gel is stable and can load the added Chinese medicinal extract. The antibacterial activity is shown in figure 1C, the free radical scavenging activity is shown in figure 2, and the long-acting release function is shown in figure 3.
Example 2
The preparation method of the bifunctional supermolecule hydrogel comprises the following steps:
step 1: weighing 10g of radix scutellariae, grinding, adding 40mL of ethanol, carrying out ultrasonic treatment, filtering, collecting filtrate, repeatedly extracting for 4 times, and concentrating under reduced pressure to 50mL to obtain radix scutellariae extract;
step 2: weighing LBA, adding ethanol, and preparing 30mg/ml stock solution;
step 3: uniformly mixing 100 mu L of LBA high-concentration stock solution with the baical skullcap root extract (230 mu L), and then adding deionized water with the volume of 7 times;
step 4: after standing, the supermolecule hydrogel can be obtained as shown in figure 1A, and has the activity of scavenging free radicals (figure 2) and long-acting release function (figure 3).
Example 3
The preparation method of the bifunctional supermolecule hydrogel comprises the following steps:
step 1: weighing 10g of radix scutellariae, grinding, adding 40mL of ethanol, carrying out ultrasonic treatment, filtering, collecting filtrate, repeatedly extracting for 4 times, and concentrating under reduced pressure to 50mL to obtain radix scutellariae extract;
step 2: weighing LBA, adding ethanol, and preparing 30mg/ml stock solution;
step 3: uniformly mixing 100 mu L of LBA high-concentration stock solution and baical skullcap root extract (250 mu L), and then adding deionized water with the volume of 7 times;
step 4: after standing, the supermolecular hydrogel can be obtained as shown in figure 1A, and has antibacterial (figure 1C), free radical scavenging activity (figure 2) and long-acting release function (figure 3).
Example 4
The preparation method of the bifunctional supermolecule hydrogel comprises the following steps:
step 1: weighing 10g of radix scutellariae, grinding, adding 40mL of ethanol, carrying out ultrasonic treatment, filtering, collecting filtrate, repeatedly extracting for 4 times, and concentrating under reduced pressure to 50mL to obtain radix scutellariae extract;
step 2: weighing LBA, adding ethanol, and preparing 30mg/ml stock solution;
step 3: uniformly mixing 100 mu L of LBA high-concentration stock solution and baical skullcap root extract (280 mu L), and then adding deionized water with the volume of 7 times;
step 4: after standing, the supermolecular hydrogel can be obtained as shown in figure 1B, and has the functions of resisting bacteria (figure 1C), scavenging free radical activity (figure 2) and long-acting release (figure 3).
Example 5
The preparation method of the bifunctional supermolecule hydrogel comprises the following steps:
step 1: weighing 10g of radix scutellariae, grinding, adding 40mL of ethanol, carrying out ultrasonic treatment, filtering, collecting filtrate, repeatedly extracting for 4 times, and concentrating under reduced pressure to 50mL to obtain radix scutellariae extract;
step 2: weighing LBA, adding ethanol, and preparing 30mg/ml stock solution;
step 3: uniformly mixing 100 mu L of LBA high-concentration stock solution and baical skullcap root extract (300 mu L), and then adding deionized water with the volume of 7 times;
step 4: and standing to obtain the supermolecule hydrogel.
Example 6
The preparation method of the bifunctional supermolecule hydrogel comprises the following steps:
step 1: weighing 10g of radix scutellariae, grinding, adding 40mL of ethanol, carrying out ultrasonic treatment, filtering, collecting filtrate, repeatedly extracting for 4 times, and concentrating under reduced pressure to 50mL to obtain radix scutellariae extract;
step 2: weighing LBA, adding ethanol, and preparing 30mg/ml stock solution;
step 3: uniformly mixing 100 mu L of LBA high-concentration stock solution and baical skullcap root extract (320 mu L), and then adding deionized water with the volume of 7 times;
step 4: and standing to obtain the supermolecule hydrogel.
Hydrogels prepared in examples 3 and 4 at different volume ratios are shown in FIG. 1B, and the resulting gels have yellow samples exuded at volume ratios of 1:3.0 and 1:3.2, indicating that all of the added herbal extract cannot be loaded at this ratio.
Example 7
The preparation method of the bifunctional supramolecular hydrogel is basically the same as that of example 1, except that: the supramolecular hydrogel factor is DB3. Molecular formula is shown as
Figure BDA0003521093830000061
The strength of the co-assembled gel obtained by the supramolecular hydrogel factor DB3 is weaker, and the release rate of drug molecules is obviously accelerated. The medicine cannot be effectively adhered to the wall of the bottle after being injected into water, has inferior effect of adhering to the stomach wall as compared with LBA, and is not beneficial to the stable release of the medicine molecules in the later period.
The foregoing describes specific embodiments of the present invention. It is to be understood that the invention is not limited to the particular embodiments described above, and that various changes and modifications may be made by one skilled in the art within the scope of the claims without affecting the spirit of the invention.

Claims (8)

1. The preparation method of the difunctional slow-release type supermolecule hydrogel for injection is characterized by comprising the following steps of:
s1, weighing radix scutellariae, grinding and extracting to obtain radix scutellariae extract;
s2, weighing supermolecule chiral gel factors, and adding ethanol to prepare high-concentration stock solution;
s3, uniformly mixing the high-concentration stock solution with the scutellaria baicalensis extracting solution, and then adding deionized water;
s4, standing to obtain supermolecule hydrogel;
the extraction method in the step S1 specifically comprises the following steps: adding ethanol into crushed radix Scutellariae, ultrasonic extracting at 40-70deg.C for 40-60 min at a feed liquid ratio of 10g to 40-50 mL for 4-5 times, mixing the extractive solutions, and concentrating to obtain radix Scutellariae extractive solution;
in the step S2, the supramolecular chiral gel factor is LBA, and the structure is as follows:
Figure QLYQS_1
2. the preparation method according to claim 1, wherein the baical skullcap root in step S1 is dried processed baical skullcap root.
3. The method according to claim 1, wherein the concentration of chiral gelator LBA in the high concentration stock solution in step S2 is 25-35mg/ml.
4. The preparation method according to claim 1, wherein the volume ratio of the high concentration stock solution to the scutellaria baicalensis extracting solution in the step S3 is 1:1.5-1:3.5.
5. The preparation method according to claim 1, wherein the volume of deionized water in step S3 is 5-10 times the volume of the high concentration stock solution mixed with the scutellaria baicalensis extract.
6. A method for preparing a bifunctional slow-release supermolecule solution for injection, which is characterized by comprising the following steps:
a1, weighing radix scutellariae, grinding and extracting to obtain radix scutellariae extract;
a2, weighing chiral gel factor LBA, and adding ethanol to prepare high-concentration stock solution;
a3, uniformly mixing the high-concentration stock solution with the scutellaria baicalensis extracting solution to obtain a solution;
the extraction method in the step A1 specifically comprises the following steps: adding ethanol into crushed radix Scutellariae, ultrasonic extracting at 40-70deg.C for 40-60 min at a feed liquid ratio of 10g to 40-50 mL for 4-5 times, mixing the extractive solutions, and concentrating to obtain radix Scutellariae extractive solution;
the structure of the LBA in step A2 is as follows:
Figure QLYQS_2
7. a bifunctional sustained-release supramolecular hydrogel for injection prepared by the preparation method of claim 1.
8. A bifunctional sustained-release supramolecular solution for injection prepared by the preparation method of claim 6.
CN202210181285.8A 2022-02-25 2022-02-25 Preparation method of difunctional slow-release supermolecule hydrogel for injection Active CN114432235B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210181285.8A CN114432235B (en) 2022-02-25 2022-02-25 Preparation method of difunctional slow-release supermolecule hydrogel for injection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210181285.8A CN114432235B (en) 2022-02-25 2022-02-25 Preparation method of difunctional slow-release supermolecule hydrogel for injection

Publications (2)

Publication Number Publication Date
CN114432235A CN114432235A (en) 2022-05-06
CN114432235B true CN114432235B (en) 2023-05-26

Family

ID=81373668

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210181285.8A Active CN114432235B (en) 2022-02-25 2022-02-25 Preparation method of difunctional slow-release supermolecule hydrogel for injection

Country Status (1)

Country Link
CN (1) CN114432235B (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100759961B1 (en) * 2006-09-08 2007-09-19 우석대학교 산학협력단 Hydrogel composition containing ketorolac tromethamine and hydrolyzed product of scutellaria radix extract
CN112641995B (en) * 2020-12-21 2021-11-23 上海交通大学 Chiral hydrogel dressing with antibacterial and repair promoting functions and preparation method and application thereof
CN113521089A (en) * 2021-07-21 2021-10-22 河南中医药大学 Baicalin hydrogel and preparation method thereof

Also Published As

Publication number Publication date
CN114432235A (en) 2022-05-06

Similar Documents

Publication Publication Date Title
CN101167749B (en) Preparing method for improving toad venom taste
CN102512482A (en) Euonymus alatus extract, blood-sugar-reducing activity thereof and application of euonymus alatus extract to preparation of products for reducing blood sugar
Wang et al. Revealing the active ingredients of the traditional Chinese medicine decoction by the supramolecular strategies and multitechnologies
Guo et al. Phillygenin from Forsythia suspensa leaves exhibits analgesic potential and anti‐inflammatory activity in carrageenan‐induced paw edema in mice
CN108079010B (en) Chinese chestnut polysaccharide pharmaceutical composition with anticancer effect and preparation method thereof
CN114432235B (en) Preparation method of difunctional slow-release supermolecule hydrogel for injection
CN100502880C (en) Notoginseng glycol-saponin composition and its preparation method and use
CN1286466C (en) Chinese medicine preparation for treating rheumatism and preparation and use
CN107625852B (en) Traditional Chinese medicine composition for clearing heat, promoting diuresis, removing blood stasis and stopping leukorrhagia as well as preparation process and application thereof
CN103099862B (en) External preparation for treating rheumatism pain disease, as well as preparation method and application thereof
CN1973853A (en) Hemostatic and analgetic medicine composition and its prepn process
Wang et al. Immunoregulatory activity of an alkaline-precipitated polysaccharide CGP-AP produced by Chaetomium globosum CGMCC 6882
CN105456528A (en) Suppository for treating gynecological inflammation and preparation method thereof
CN114344358A (en) Eucommia ulmoides composition containing aucubin and geniposide, preparation and application
CN105168612A (en) Drug for treating piglet diarrhea, as well as preparation method, detection method and application thereof
CN108403621B (en) Multi-target-point antibacterial acne-removing gel and preparation method thereof
JPH0267301A (en) Polysaccharide, isolation thereof and drug composition containing the same
CN107638522B (en) Traditional Chinese medicine composition for mainly treating wind-cold type common cold and relieving exterior syndrome and clearing heat as well as preparation process and application thereof
CN113577136B (en) Gelsemium elegans attenuated and anti-tumor pig gall powder processed product and preparation method thereof
LU503132B1 (en) Suillus luteus polysaccharide, its preparation method and medical application
CN106668081B (en) High-activity drying method of golden ganoderma medicinal material
CN101181336A (en) Method for refining valid target of bitter gourd for dropping blood sugar
CN1233399C (en) Effervescence tablet of radix isatidis and its preparation
CN106491674A (en) A kind of CHUANXINLIAN ZHUSHEYE containing high-load andrographolide and preparation method thereof
CN105496962A (en) Liposome with sarafloxacin hydrochloride and traditional Chinese medicine extract and method for preparing liposome

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant